相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In silico strategies for probing novel DPP-IV inhibitors as anti-diabetic agents
Shweta Sharma et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
An Insight into the Synthesis and SAR of 2,4-Thiazolidinediones (2,4-TZD) as Multifunctional Scaffold: A Review
Navjot Singh Sethi et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2020)
Morpholine as ubiquitous pharmacophore in medicinal chemistry: Deep insight into the structure-activity relationship (SAR)
Archana Kumari et al.
BIOORGANIC CHEMISTRY (2020)
New chalcone-type compounds and 2-pyrazoline derivatives: synthesis and caspase-dependent anticancer activity
Mohamed Chouiter et al.
FUTURE MEDICINAL CHEMISTRY (2020)
Mining of potential dipeptidyl peptidase-IV inhibitors as anti-diabetic agents using integrated in silico approaches
Shweta Sharma et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2020)
Steroidal pyrazolines as a promising scaffold in drug discovery
Ranju Bansal et al.
FUTURE MEDICINAL CHEMISTRY (2020)
New flavonoid - N,N-dibenzyl(N-methyl)amine hybrids: Multi-target-directed agents for Alzheimer′s disease endowed with neurogenic properties
Martin Estrada-Valencia et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)
Medicinal chemistry of indole derivatives: Current to future therapeutic prospectives
Archana Kumari et al.
BIOORGANIC CHEMISTRY (2019)
Phenoxyethyl Piperidine/Morpholine Derivatives as PAS and CAS Inhibitors of Cholinesterases: Insights for Future Drug Design
Yaghoub Pourshojaei et al.
SCIENTIFIC REPORTS (2019)
Zinc/alogliptin combination attenuates testicular toxicity induced by doxorubicin in rats: Role of oxidative stress, apoptosis and TGF-β1/NF-κB signaling
Ahmed M. Kabel
BIOMEDICINE & PHARMACOTHERAPY (2018)
Facile synthesis of some pyrazoline-based compounds with promising anti-inflammatory activity
Nahed M. Eid et al.
FUTURE MEDICINAL CHEMISTRY (2018)
Synthesis and evaluation of thiazolidinone-pyrazole conjugates as anticancer and antimicrobial agents
Mahima Bhat et al.
FUTURE MEDICINAL CHEMISTRY (2018)
Linagliptin potentiates the effect of L-dopa on the behavioural, biochemical and immunohistochemical changes in experimentally-induced Parkinsonism: Role of toll-like receptor 4, TGF-beta 1, NF-kappa B and glucagon-like peptide 1
Ahmed M. Kabel et al.
PHYSIOLOGY & BEHAVIOR (2018)
Synthesis, molecular modeling and biological screening of some pyrazole derivatives as antileishmanial agents
Adnan A. Bekhit et al.
FUTURE MEDICINAL CHEMISTRY (2018)
Combating Diseases with Computational Strategies Used for Drug Design and Discovery
Farahnaz R. Makhouri et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2018)
Role of computer-aided drug design in modern drug discovery
Stephani Joy Y. Macalino et al.
ARCHIVES OF PHARMACAL RESEARCH (2015)
FAF-Drugs3: a web server for compound property calculation and chemical library design
David Lagorce et al.
NUCLEIC ACIDS RESEARCH (2015)
Structure based virtual screening of MDPI database: Discovery of structurally diverse and novel DPP-IV inhibitors
Omprakash Tanwar et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Dipeptidyl Peptidase IV and Its Inhibitors: Therapeutics for Type 2 Diabetes and What Else?
Lucienne Juillerat-Jeanneret
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Facile microwave-assisted synthesis of substituted benzofuran derivatives
Junqiang Liu et al.
RESEARCH ON CHEMICAL INTERMEDIATES (2014)
Evaluation of Silica-H2SO4 as an Efficient Heterogeneous Catalyst for the Synthesis of Chalcones
Aeysha Sultan et al.
MOLECULES (2013)
Discovery and pharmacological characterization of N-[2-({2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}amino)-2-methylpropyl]-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide hydrochloride (anagliptin hydrochloride salt) as a potent and selective DPP-IV inhibitor
Noriyasu Kato et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Discovery of 6-(Aminomethyl)-5-(2,4-dichlorophenyl)-7-methylimidazo[1,2-a]pyrimidine-2-carboxamides as Potent, Selective Dipeptidyl Peptidase-4 (DPP4) Inhibitors
Wei Meng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
Jonathan B. Baell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Synthesis and antiviral activity of new pyrazole and thiazole derivatives
Osama I. El-Sabbagh et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
(1,3-Diphenyl-1H-pyrazol-4-yl)-methylamine Analogues as Inhibitors of Dipeptidyl Peptidases
Tsu Hsu et al.
JOURNAL OF THE CHINESE CHEMICAL SOCIETY (2009)
Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions
Peter Ertl et al.
JOURNAL OF CHEMINFORMATICS (2009)
DPP-4 inhibitors and GLP-1 analogues: for whom? Which place for incretins in the management of type 2 diabetic patients?
S. Halimi
DIABETES & METABOLISM (2008)
Synthesis and biological evaluation of pyrazoline analogues with β-amino acyl group as dipeptidyl peptidase IV inhibitors
Mi Ae Jun et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2008)
Synthesis, Fungicidal, and Insecticidal Activities of β-Methoxyacrylate-Containing N-Acetyl Pyrazoline Derivatives
Pei-Liang Zhao et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2008)
4,5-diarylisoxazole HSP90 chaperone inhibitors: Potential therapeutic agents for the treatment of cancer
Paul A. Brough et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Benchmarking the reliability of QikProp. Correlation between experimental and predicted values
Leukothea Ioakimidis et al.
QSAR & COMBINATORIAL SCIENCE (2008)
Dipeptidyl peptidase IV inhibitors and the incretin system in type 2 diabetes mellitus
Alissa K. Langley et al.
PHARMACOTHERAPY (2007)
Modeling assisted rational design of novel, potent, and selective pyrrolopyrimidine DPP-4 inhibitors
Ying-Duo Gao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
Richard A. Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
KR-62436, 6-{2-[2-(5-cyano-4,5-dihydropyrazol-1-yl)-2-oxoethylamino]ethylamino}nicotinonitrile, is a novel dipeptidyl peptidase-IV (DPP-IV) inhibitor with anti-hyperglycemic activity
KR Kim et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Discovery of potent and selective β-homophenylalanine based dipeptidyl peptidase IV inhibitors
JY Xu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Substituted piperazines as novel dipeptidyl peptidase IV inhibitors
LL Brockunier et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
分享论文
